The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
Open accessAbstract
Summary: Obesity is reaching epidemic proportions with recent worldwide figures estimated at 1.4 billion and rising year‐on‐year. Obesity affects all socioeconomic backgrounds and ethnicities and is a pre‐requisite for metabolic syndrome. Metabolic syndrome is a clustering of risk factors, such as central obesity, insulin resistance, dyslipidaemia and hypertension that together culminate in the increased risk of type 2 diabetes mellitus and cardiovascular disease. As these conditions are among the leading causes of deaths worldwide and metabolic syndrome increases the risk of type 2 diabetes mellitus fivefold and cardiovascular disease threefold, it is of critical importance that a precise definition is agreed upon by all interested parties. Also of particular interest is the relationship between metabolic syndrome and cancer. Metabolic syndrome has been associated with a plethora of cancers including breast, pancreatic, colon and liver cancer. Furthermore, each individual risk factor for metabolic syndrome has also an association with cancer. Our review collates internationally generated information on metabolic syndrome, its many definitions and its associations with life‐threatening conditions including type 2 diabetes mellitus, cardiovascular disease and cancer, providing a foundation for future advancements on this topic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedAlberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 2×
“diabetes in 2000 and projected to increase to 366 million by 2,030 (47).”
BackgroundHeart Disease and Stroke Statistics—2014 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,215
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
Cited by
Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0495-2 · Cited by 2,357
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Ranasinghe, P., Mathangasinghe, Y., Jayawardena, R., Hills, A. P., & Misra, A. (2017) · BMC Public Health · doi:10.1186/s12889-017-4041-1 · Cited by 746
Tahapary, D. L., Pratisthita, L. B., Fitri, N. A., Marcella, C., Wafa, S., Kurniawan, F., Rizka, A., Tarigan, T. J. E., Harbuwono, D. S., Purnamasari, D., et al. (2022) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102581 · Cited by 614
The microbiota–gut–brain axis in obesity
Torres-Fuentes, C., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30147-4 · Cited by 612
Cardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D. J., & Mather, K. J. (2017) · Translational Research · doi:10.1016/j.trsl.2017.01.001 · Cited by 568
Sex differences in cardiometabolic disorders
Gerdts, E., & Regitz-Zagrosek, V. (2019) · Nature Medicine · doi:10.1038/s41591-019-0643-8 · Cited by 519
Nutraceuticals: opening the debate for a regulatory framework
Santini, A., Cammarata, S. M., Capone, G., Ianaro, A., Tenore, G. C., Pani, L., & Novellino, E. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13496 · Cited by 401
Role of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 384
Distinct but complementary contributions of PPAR isotypes to energy homeostasis
Dubois, V., Eeckhoute, J., Lefebvre, P., & Staels, B. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88894 · Cited by 383
Mitochondrial dysfunction in metabolic syndrome
Prasun, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165838 · Cited by 364
β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes
Hudish, L. I., Reusch, J. E. B., & Sussel, L. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129188 · Cited by 336
Lippert, K., Kedenko, L., Antonielli, L., Kedenko, I., Gemeier, C., Leitner, M., Kautzky-Willer, A., Paulweber, B., & Hackl, E. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0184 · Cited by 323
Guembe, M. J., Fernandez-Lazaro, C. I., Sayon-Orea, C., Toledo, E., Moreno-Iribas, C., for the RIVANA Study Investigators, Cosials, J. B., Reyero, J. B., Martínez, J. D., Diego, P. G., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01166-6 · Cited by 315
Nolan, P. B., Carrick-Ranson, G., Stinear, J. W., Reading, S. A., & Dalleck, L. C. (2017) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.07.004 · Cited by 308
Production of Bioactive Peptides by Lactobacillus Species: From Gene to Application
Raveschot, C., Cudennec, B., Coutte, F., Flahaut, C., Fremont, M., Drider, D., & Dhulster, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02354 · Cited by 307
Depommier, C., Van Hul, M., Everard, A., Delzenne, N. M., De Vos, W. M., & Cani, P. D. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1737307 · Cited by 269
Suriano, F., Vieira-Silva, S., Falony, G., Roumain, M., Paquot, A., Pelicaen, R., Régnier, M., Delzenne, N. M., Raes, J., Muccioli, G. G., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01097-8 · Cited by 263
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Implications of altered NAD metabolism in metabolic disorders
Okabe, K., Yaku, K., Tobe, K., & Nakagawa, T. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0527-8 · Cited by 223
Phytotherapy in the management of diabetes: A review
Governa, P., Baini, G., Borgonetti, V., Cettolin, G., Giachetti, D., Magnano, A., Miraldi, E., & Biagi, M. (2018) · Molecules · doi:10.3390/molecules23010105 · Cited by 182
Chen, Y. Q., Pottanat, T. G., Siegel, R. W., Ehsani, M., Qian, Y.-W., Zhen, E. Y., Regmi, A., Roell, W. C., Guo, H., Luo, M. J., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000781 · Cited by 147
Fragiadakis, G. K., Wastyk, H. C., Robinson, J. L., Sonnenburg, E. D., Sonnenburg, J. L., & Gardner, C. D. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa046 · Cited by 138
Cao, C., Yang, S., & Zhou, Z. (2019) · Endocrine · doi:10.1007/s12020-019-02055-z · Cited by 99
Saraf-Bank, S., Haghighatdoost, F., Esmaillzadeh, A., Larijani, B., & Azadbakht, L. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.173 · Cited by 89
Amanat, S., Sinaei, E., Panji, M., MohammadporHodki, R., Bagheri-Hosseinabadi, Z., Asadimehr, H., Fararouei, M., & Dianatinasab, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.562895 · Cited by 70
Åberg, F., Färkkilä, M., & Männistö, V. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14271 · Cited by 63
Le Barz, M., Daniel, N., Varin, T. V., Naimi, S., Demers‐Mathieu, V., Pilon, G., Audy, J., Laurin, É., Roy, D., Urdaci, M. C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801672r · Cited by 63
Mulligan, A. A., Lentjes, M. A. H., Luben, R. N., Wareham, N. J., & Khaw, K.-T. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1223-z · Cited by 62
Dianatinasab, A., Koroni, R., Bahramian, M., Bagheri-Hosseinabadi, Z., Vaismoradi, M., Fararouei, M., & Amanat, S. (2020) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2020.06.004 · Cited by 56
Hedermann, G., Hedley, P. L., Thagaard, I. N., Krebs, L., Ekelund, C. K., Sørensen, T. I. A., & Christiansen, M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252343 · Cited by 48
Molecular mechanisms governing offspring metabolic programming in rodent models of in utero stress
Christoforou, E. R., & Sferruzzi-Perri, A. N. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03566-z · Cited by 44
Delpierre, C., Fantin, R., Barboza-Solis, C., Lepage, B., Darnaudéry, M., & Kelly-Irving, M. (2016) · BMC Public Health · doi:10.1186/s12889-016-3484-0 · Cited by 42
Yang, S., Li, D., Yu, Z., Li, Y., & Wu, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709629 · Cited by 40
“…(AS), atherosclerotic cardiovascular diseases (ASCVDs), and metabolic diseases (including diabetes, obesity, dyslipidemia, and nonalcoholic fatty liver disease (NAFLD)) are serious hazards to human health (O’Neill and O’Driscoll, 2015; Herrington et al., 2016).”
BackgroundCardiometabolic health in Turner syndrome
Davis, S. M., & Geffner, M. E. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31678 · Cited by 37
Zhu, L., Yang, W. J., Spence, C. B., Bhimla, A., & Ma, G. X. (2021) · Healthcare · doi:10.3390/healthcare9111518 · Cited by 36
Wang, H., Wang, Y., Li, X., Deng, X., Kong, Y., Wang, W., & Zhou, Y. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01716-0 · Cited by 34
Naghipour, M., Joukar, F., Nikbakht, H.-A., Hassanipour, S., Asgharnezhad, M., Arab-Zozani, M., & Mansour-Ghanaei, F. (2021) · International Journal of Endocrinology · doi:10.1155/2021/8862456 · Cited by 26
Low serum ZAG levels correlate with determinants of the metabolic syndrome in Chinese subjects
Wang, L., Liu, M., Ning, D., Zhu, H., Shan, G., Wang, D., Ping, B., Yu, Y., Yang, H., Yan, K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00154 · Cited by 21
Azevedo, M. D. G. B. D., Pedrosa, R. S., Aoqui, C. M., Martins, R. R., & Nagashima Junior, T. (2017) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000216089 · Cited by 13
Asato, C. B. H., Nelson-Hurwitz, D. C., Lee, T., & Grandinetti, A. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0090 · Cited by 11
Miller, M., Bhatt, D. L., Brinton, E. A., Jacobson, T. A., Steg, P. G., Pineda, A. L., Ketchum, S. B., Doyle, R. T., Tardif, J.-C., & Ballantyne, C. M. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead114 · Cited by 11
Metadata
- Authors
- O'Neill, S., & O'Driscoll, L.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2014-11-18
- Volume
- 16
- Issue
- 1
- Pages
- 1-12
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2101964276
- Cited by
- 1,547
- References
- 76
- FWCI
- 46.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.